Rapid, reliable identification of carbapenemase producing organisms is essential to guide effective antibiotic stewardship, inform treatment decisions and give infection prevention and control teams the intelligence they need to act quickly and with confidence.

Carbapenem resistant Gram negative bacteria, including Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii, are a growing cause of healthcare associated infection (HAI), combining high levels of resistance with a well documented capacity for transmission in both hospital and community settings. The consequences of delayed detection are significant, with limited therapeutic options and increased morbidity.

Mast's range of rapid carbapenemase detection products is designed to meet this challenge, supporting laboratories with solutions that are as straightforward to use as they are dependable.